Jyoti Kumar, M.D.

Jyoti Kumar, M.D., pathologist with Clinical Pathology Associates
Sub-Specialties
HematopathologyMolecular

Joined Clinical Pathology Associates: 2024

Primary Service Location:

Rotating sites

Board Certifications:

  • Anatomic and Clinical Pathology (2020)
  • Hematopathology (2021)
  • Molecular Genetic Pathology (2022)

Fellowships:

  • Molecular Genetic Pathology, Stanford University
  • Hematopathology, Stanford University

Residency:

  • Standford University (AP/CP)
  • Baylor College of Medicine (AP/CP)

Medical School:

  • Ross University School of Medicine

Undergraduate Education:

  • Cornell University

Additional Education:

  • Rutgers University – Master of Science: Biomedical Sciences

Publications:

  • Kumar J, Lu R, Khanna V, Stehr H, Spinner M, Silva O, Fernandez-Pol S, Oak J, Greenberg PL, Tan B. Correlation of Mutational Profiles and Cytogenetics with Morphologic Dysplasia in Myelodysplastic Syndromes. In preparation.
  • Kumar J, Lewis NE, Londono D, Sun X, Gao Q, Arcila ME, Roshal M, Zhang Y, Xiao W, Chan A. Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and
    SF3B1 mutations. Haematologica. Submitted.
  • Khanna V, Lu R, Kumar J, Stehr H, Spinner M, Silva O, Fernandez-Pol S, Oak J, Tan B, Greenberg PL. Clinical, Molecular, and Prognostic Features of the 2022 WHO and ICC Classification Systems for Myelodysplastic Neoplasms. Leuk Res. Submitted.
  • Volaric AK, Kumar J, Nicholas V, Saleem A, Suarez CJ, Natkunam Y. Mutational Profiling of Epstein Barr Virus-Positive Mucocutaneous Ulcer. Arch Pathol Lab Med. Submitted.
  • Kumar J, Ewalt MD, Zhang Y, Yao J, Thompson MC, Dogan A. Novel identification of t(14;18) q32;q21)/IGH::MALT1 in chronic lymphocytic leukemia. Br J Haematol. Accepted.
  • Kumar J, Petrova-Drus, K. Acute leukemia with predominantly myeloid differentiation and TBL1XR1::CSF1R fusion. Blood. 2023;142(14):1253.4
  • Xiao A, Shahmarvand N, Nagy A, Kumar J, Ziffle JV, Devine P, Huang F, Lezama L, Li P, Ohgami RS. TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature. Front Oncol. 2023;13:1174606.
  • Kumar J, Patel S, Chang A, Mukherjee S, Small C, Gollapudi S, Butzmann A, Jangam D, Weinberg OK, George TI, Zehnder JL, Ohgami RS. Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic
    malignancies, cytogenetic abnormalities, and WHO category. Hum Pathol. 2023;135:45-53.
  • Testa S, Kumar J, Goodell AJ, Zehnder JL, Alexander KM, Sidana S, Arai S, Witteles RM, Liedtke M. Prevalence, Mutational Spectrum and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential in Plasma Cell Dyscrasias. Semin Oncol.
    2022;49(6):465-475.
  • Kumar J, Alspach AE, Zucker JP, Gratzinger DA. Systemic presentation of somatic TET2 mutated B-cell lymphoma in a child with Kabuki syndrome and germline KMT2D variant. Am J Clin Pathol. 2022;158(5):564-569.
  • Saglam A, Singh K, Kumar J, Gollapudi S, Mukherjee S, Singh A, Butzmann A, Kaplan L, Charambalos A, Ai W, Fakhri B, Rajkovic A, Wen KW, Onodera C, Van Ziffle J, Devine P, Ohgami RS. Copy number loss at chromosome 14q11.2 correlates with the proportion of T-cells in biopsies and helps identify T-cell neoplasms. Arch Pathol Lab Med. Accepted.
  • Kumar J, Al-Kawaaz M, Martin BA, Hegazi MM, Tan B, Gratzinger DA. Histiocytic sarcoma with CCND1 gene rearrangement clonally related and transdifferentiated from mantle cell lymphoma. Am J Clin Pathol. 2022;158(4):449-455.
  • Saglam A, Singh K, Gollapudi S, Kumar J, Brar N, Butzmann A, Warnke R, Ohgami RS. Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the
    epidemiologic, clinical and pathologic features of 45 cases. Int J Lab Hematol. 2022;44(4):700-711.
  • Singh K, Gollapudi S, Kumar J, Butzmann A, Small C, Kreimer S, Saglam EA, Warnke R, Silva O, Ohgami RS. Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, PDGFRB Mutation and p53 Expression: Clonal Origins of a Rare
    Disease. Front Oncol. 2022;12:857606.
  • Butzmann A, Sridhar K, Jangam D, Song H, Singh A, Kumar J, Chisholm K, Pinsky B, Huang F, Ohgami R. Mutations in JAK/STAT and NOTCH1 signaling pathway genes are enriched in post-transplant lymphoproliferative disorders. Front Oncol. 2022;11:790481.
  • Butzmann A†, Kumar J†, Sridhar K, Gollapudi S, Ohgami RS. A Review of Genetic Abnormalities in Unicentric and Idiopathic Multicentric Castleman Disease. Biology. 2021;
    10(4):251. †Equal contribution.
  • Singh K, Gollapudi S, Mittal S, Small C, Kumar J, Ohgami RS. Point mutation specific antibodies in B-cell and T-cell lymphomas and leukemias: Targeting IDH2, KRAS, BRAF and other biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2. Diagnostics. 11(4):600.
    *Maiden name: Duggal
  • Ling H, Sridhar K, Gollapudi S, Kumar J, Ohgami RS. Measurement of cell volume using in-line digital holography. Microscopy. 2021;70(4):333-339.
  • Wang L, Ashraf DC, Kinde B, Ohgami RS, Kumar J, Kersten RC. Haploid B-cell Acute Lymphoblastic Leukemia Presenting as an Isolated Orbital Mass Prior to Systemic Involvement: A Case Report and Review of the Literature. Diagnostics. 2021;11(1):25.
  • Singh K, Mittal S, Gollapudi S, Butzmann A, Kumar J, Ohgami RS. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity. Int J Lab
    Hematol. 2021;43(2):324-328.
  • Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS. LMO2 Expression Distinguishes T-Lymphoblastic Leukemia/Lymphoma From Indolent T-Lymphoblastic Proliferations. Histopathology. 2020 Dec;77(6):984-988.
  • Butzmann A, Sridhar K, Jangam D, Kumar J, Sahoo MK, Shahmarvand N, Warnke R, Rangasamy E, Pinsky BA, Ohgami RS. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. Int J Mol Med. 2020 Oct;46(4):1466-1476.
  • Hoffmann JC, Atwater SK, Hong E, Kumar J, Khodadoust M, Kim Y, Ohgami RS. A Long-Term Study of Persistent Sézary Syndrome: Evidence for Antigen Shift by Multiparameter Flow Cytometry and Its Significance in Overall Survival. Am J Dermatopathol. 2020;42(6):389-396.
  • Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA. Histology-Independent Signature Distinguishes Kikuchi-Fujimoto Disease/Systemic Lupus Erythematosus-Associated Lymphadenitis From Benign and Malignant Lymphadenopathies. Am J Clin Pathol. 2020;154(2):215-224.
  • Kumar J, Butzmann A, Wu S, Easly S, Zehnder JL, Warnke RA, Bangs CD, Jangam D, Cherry A, Lau J, Nybakken G, Ohgami RS. Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. Am J Surg Pathol. 2019;43(12):1720-1725.
  • Ravoori MK, Han L, Singh SP, Dixon K, Duggal J*, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V. Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model. PLoS One. 2013; 8(6):e62371. *Maiden name: Duggal
  • Ravoori M, Duggal J*, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V. Visualizing the Prostate Gland by MR Imaging in Young and Old Mice. PLoS One. 2013; 8(3):e55746. *Maiden name: Duggal
  • Duggal J*, Harrison JS, Studzinski GP, Wang X. Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid
    and vitamin D analog doxercalciferol in human leukemia cells. MicroRNA. 2012; 1(1):26-33.6 *Maiden name: Duggal